戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ystrophy, facioscapulohumeral dystrophy, and limb-girdle muscular dystrophy).
2 mains in dysferlin, whose gene is mutated in limb girdle muscular dystrophy.
3 lar dystrophy resembling what is observed in limb girdle muscular dystrophy.
4 protease calpain-3 cause autosomal recessive limb girdle muscular dystrophy.
5 -sarcoglycan-null (scgd(-/-)) mouse model of limb-girdle muscular dystrophy.
6  for delta-sarcoglycan (scgd-/-), a model of limb-girdle muscular dystrophy.
7 nale for the development of gene therapy for limb-girdle muscular dystrophy.
8  sarcolemma and produce one of four types of limb-girdle muscular dystrophy.
9 coglycan have been identified in humans with limb-girdle muscular dystrophy.
10 a, and delta) have been found in humans with limb-girdle muscular dystrophy.
11 ns lead to four forms of autosomal recessive limb-girdle muscular dystrophy.
12 mplex may be involved in the pathogenesis of limb-girdle muscular dystrophy.
13 rburg syndrome, to mild forms of adult-onset limb-girdle muscular dystrophy.
14 d its absence is common to both Duchenne and limb girdle muscular dystrophies.
15 stitute promising therapeutic strategies for limb-girdle muscular dystrophies.
16 l emphasis on animal models for Duchenne and limb-girdle muscular dystrophies.
17 tions in the encoding genes cause congenital/limb-girdle muscular dystrophies.
18                                              Limb-girdle muscular dystrophy 1A (LGMD1A [MIM 159000])
19 exia-1 (DYX1) and TMOD4 a candidate gene for limb girdle muscular dystrophy 1B (LGMD1B).
20                 Of these, Emery-Dreifuss and Limb-Girdle muscular dystrophy 1B mainly affect striated
21 nsistent with the mild phenotype observed in Limb-girdle muscular dystrophy-1C (LGMD-1C) in humans, c
22 is of Cav-3-related muscle diseases, such as limb-girdle muscular dystrophy-1C, distal myopathy, and
23 in-3 expression in skeletal muscle resembles limb-girdle muscular dystrophy-1C.
24                                              Limb girdle muscular dystrophy 1D/1E (OMIM nomenclature
25                                              Limb girdle muscular dystrophy 2A is due to loss-of-func
26 fic family member calpain 3 (CAPN3) underlie limb-girdle muscular dystrophy 2A.
27        Mutations in the dysferlin gene cause limb girdle muscular dystrophy 2B (LGMD2B) and Miyoshi m
28 tivity in a mouse model of the human disease limb girdle muscular dystrophy 2B (LGMD2B), caused by a
29 +) signaling offers a therapeutic avenue for limb girdle muscular dystrophy 2B and Miyoshi myopathy p
30                                              Limb girdle muscular dystrophy 2B and Miyoshi myopathy w
31 We have developed a new diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy,
32 EY POINTS: Dysferlin, the protein missing in limb girdle muscular dystrophy 2B and Miyoshi myopathy,
33             Dysferlinopathies, most commonly limb girdle muscular dystrophy 2B and Miyoshi myopathy,
34 t mutations in dysferlin are responsible for limb girdle muscular dystrophy 2B and Miyoshi myopathy.
35          In our analysis of 12 patients with limb girdle muscular dystrophy 2B or Miyoshi myopathy, t
36 ssive muscular dystrophies Miyoshi myopathy, limb girdle muscular dystrophy 2B, and distal anterior c
37  HDAC6 and dysferlin, the protein mutated in limb girdle muscular dystrophy 2B.
38             Deficiency of dysferlin leads to limb-girdle muscular dystrophy 2B (LGMD2B) and Miyoshi m
39 ne resulting in dysferlin-deficiency lead to limb-girdle muscular dystrophy 2B and Myoshi myopathy in
40 ein dysferlin, underlie Miyoshi myopathy and limb-girdle muscular dystrophy 2B in humans and produce
41                                              Limb-girdle muscular dystrophy 2B, Miyoshi myopathy, and
42 arries mutations in patients presenting with limb-girdle muscular dystrophy 2B.
43                          Autosomal recessive limb girdle muscular dystrophies 2C-2F represent a famil
44                                              Limb girdle muscular dystrophy 2C is caused by mutations
45                                              Limb-girdle muscular dystrophies 2C-F represent a family
46 rophy, congenital muscular dystrophy 1A, and limb girdle muscular dystrophy 2D.
47  alpha sarcoglycan (Sgca), a mouse model for limb girdle muscular dystrophy 2D.
48 emains unclear why mutations in Tcap lead to limb-girdle muscular dystrophy 2G (LGMD2G) in human pati
49                                              Limb girdle muscular dystrophy 2H is caused by mutations
50  32 (TRIM32) are responsible for the disease limb-girdle muscular dystrophy 2H (LGMD2H).
51 ngenital muscular dystrophy type 1C (MDC1C), limb girdle muscular dystrophy 2I (LGMD2I) and congenita
52 nerate a wide range of pathologies from mild limb girdle muscular dystrophy 2I (LGMD2I), severe conge
53 hology in FKRP P448Lneo(-) mice, a model for limb girdle muscular dystrophy 2I.
54                                              Limb-girdle muscular dystrophy 2I (LGMD2I) is caused by
55 FKRPP448L-mutant mouse representing moderate limb-girdle muscular dystrophy 2I.
56 riable clinical phenotypes, most commonly as limb-girdle muscular dystrophy 2I.
57          Human tibial muscular dystrophy and limb-girdle muscular dystrophy 2J are caused by mutation
58  one of two previously identified disorders, limb-girdle muscular dystrophy 2L and non-dysferlin Miyo
59 various proteins known to be involved in the limb-girdle muscular dystrophies (alpha, beta, gamma, de
60 lly, we have identified an important case of limb girdle muscular dystrophy and cardiomyopathy with n
61 ng the pathogenesis of sarcoglycan deficient limb-girdle muscular dystrophies and for the development
62 t on wild type (WT) Cav3 and associates with limb-girdle muscular dystrophy and cardiomyopathy.
63 ense mutation (Thr192-->Met) in a woman with limb-girdle muscular dystrophy and cognitive impairment.
64 emonstrate that FLN2 protein localization in limb-girdle muscular dystrophy and Duchenne muscular dys
65 anging from congenital muscular dystrophy to limb-girdle muscular dystrophy and identified allelic IS
66 tinct diseases, including three new forms of limb-girdle muscular dystrophy and one form of congenita
67  viral vectors have recently started, one in limb-girdle muscular dystrophy and one in Duchenne muscu
68 trophy (EDMD), dilated cardiomyopathy (DCM), limb-girdle muscular dystrophy, and Hutchison-Gilford pr
69 ma-sarcoglycan result in autosomal recessive limb girdle muscular dystrophy (AR-LGMD).
70                                              Limb-girdle muscular dystrophies are a genetically diver
71                                          The limb-girdle muscular dystrophies are a group of disorder
72 mma is dramatically reduced in patients with limb-girdle muscular dystrophy arising from the loss of
73 al Specialist Commissioning Team service for limb-girdle muscular dystrophies at Newcastle (UK).
74 c hamster is a naturally occurring model for limb-girdle muscular dystrophy caused by a primary defic
75 models of muscular dystrophy, including DM1, limb-girdle muscular dystrophy, congenital merosin-defic
76 c conduction-system disease, and adult-onset limb-girdle muscular dystrophy (FDC, conduction disease,
77 uscular dystrophy type 2A is the most common limb girdle muscular dystrophy form worldwide.
78  abnormalities were not found, we identified limb-girdle muscular dystrophy gene mutations affecting
79 ent a genetically distinct subset within the limb-girdle muscular dystrophy group.
80  understanding the molecular pathogenesis of limb-girdle muscular dystrophy has been gained.
81       Some patients with autosomal recessive limb-girdle muscular dystrophy have mutations in the gen
82 o sib pairs) with a predominantly late onset limb-girdle muscular dystrophy in whom an absence of mer
83                                              Limb-girdle muscular dystrophy is a class of disorders e
84 stroglycan causes an array of congenital and limb girdle muscular dystrophies known as dystroglycanop
85           Dysferlin, the gene product of the limb girdle muscular dystrophy (LGMD) 2B locus, encodes
86        Duchenne muscular dystrophy (DMD) and limb girdle muscular dystrophy (LGMD) 2C-F result from t
87                                              Limb girdle muscular dystrophy (LGMD) 2F is caused by mu
88 pes including Walker-Warburg syndrome (WWS), limb girdle muscular dystrophy (LGMD) 2I and congenital
89 feature of four types of autosomal recessive limb girdle muscular dystrophy (LGMD) is that mutations
90                PTP dysregulation is found in limb girdle muscular dystrophy (LGMD) type 2B myoblasts
91  involvement, to relatively mild adult onset limb girdle muscular dystrophy (LGMD).
92                           Autosomal dominant limb girdle muscular dystrophy (LGMD-1C) in humans is du
93 down-regulated in patients with this form of limb girdle muscular dystrophy (LGMD-1C).
94                                              Limb-girdle muscular dystrophies (LGMD) are a heterogene
95 eneity which has long been recognized in the limb-girdle muscular dystrophies (LGMD) has been shown t
96                                          The limb-girdle muscular dystrophies (LGMD) have recently un
97 rcoglycan complex is known to be involved in limb-girdle muscular dystrophy (LGMD) and is composed of
98                                Four types of limb-girdle muscular dystrophy (LGMD) are known to be ca
99 s in POMT2 have also been linked to a milder limb-girdle muscular dystrophy (LGMD) phenotype, named L
100 ereditary inclusion body myopathy (hIBM) and limb-girdle muscular dystrophy (LGMD), are a genetically
101 in a family of 4 with cardiac arrhythmia and limb-girdle muscular dystrophy (LGMD).
102                           Autosomal dominant limb-girdle muscular dystrophy (LGMD-1C) in humans is du
103 dentified a novel autosomal dominant form of limb-girdle muscular dystrophy (LGMD-1C) in humans that
104 cation of a new locus for autosomal dominant limb-girdle muscular dystrophy (LGMD1) on 7q.
105 ent expressing an autosomal dominant form of limb girdle muscular dystrophy (LGMD1A).
106 mple, in the diagnosis of autosomal dominant limb-girdle muscular dystrophy (LGMD1A), it is not alway
107 ases, including Emery-Dreifuss (EDMD2/3) and Limb-Girdle muscular dystrophy (LGMD1B).
108 patients with sarcoglycanopathies, which are limb-girdle muscular dystrophies (LGMD2C-2F) caused by m
109                             The other 18 had limb girdle muscular dystrophy (LGMD2I).
110                          Autosomal recessive limb-girdle muscular dystrophies (LGMDs) are genetically
111     Another group of MD's referred to as the limb-girdle muscular dystrophies (LGMDs) can affect boys
112 l recessive muscular dystrophy to the milder limb-girdle muscular dystrophies (LGMDs).
113 her types of muscular dystrophies, including limb-girdle muscular dystrophies (LGMDs).
114 -to-date analysis of current knowledge about limb-girdle muscular dystrophies (LGMDs).
115 ts presented as an adult or adolescent-onset limb-girdle muscular dystrophy, one presented with isola
116 rotein that may be a good candidate gene for limb-girdle muscular dystrophy or other neuromuscular di
117 nderlying the molecular mechanism of several limb-girdle muscular dystrophies, particularly those whe
118 ly step in the diagnostic algorithm of adult limb-girdle muscular dystrophy patients.
119 e dystrophin-glycoprotein complex, produce a limb-girdle muscular dystrophy phenotype; however, the p
120 tions in these genes might also cause milder limb-girdle muscular dystrophy phenotypes.
121 henne muscular dystrophy or various forms of limb-girdle muscular dystrophies respectively.
122 ption of the cardiac involvement in forms of limb girdle muscular dystrophies secondary to abnormal g
123                    Miyoshi myopathy (MM) and limb-girdle muscular dystrophy subtype 2B (LGMD2B) map t
124 uscular dystrophies ranging from adult onset limb girdle muscular dystrophies to severe congenital fo
125 uscular dystrophies ranging from adult onset limb girdle muscular dystrophies to severe congenital fo
126  a broad spectrum of disorders, ranging from limb girdle muscular dystrophy to Walker-Warburg syndrom
127                                              Limb Girdle Muscular Dystrophies type 2I (LGMD2I), a rec
128    The protein dysferlin, the product of the Limb Girdle Muscular Dystrophy type 2 locus, has been sh
129 ease calpain 3 (CAPN3) result in the disease limb girdle muscular dystrophy type 2A (LGMD2A).
130                                 Diagnosis of limb girdle muscular dystrophy type 2A can be complex du
131                                              Limb girdle muscular dystrophy type 2A is the most commo
132 enders patients deficient in calpain 3 as in limb girdle muscular dystrophy type 2A, albeit in a mild
133 akness was generally milder than observed in limb girdle muscular dystrophy type 2A, but affected the
134 cle function, since mutations in CAPN3 cause limb girdle muscular dystrophy type 2A.
135 tease calpain 3 (C3), the protein mutated in limb girdle muscular dystrophy type 2A.
136 PN3 result in an autosomal recessive form of limb girdle muscular dystrophy type 2A.
137                                              Limb girdle muscular dystrophy type 2B and Miyoshi myopa
138        Mutations in the dysferlin gene cause limb girdle muscular dystrophy type 2B and Miyoshi myopa
139 ficiency of the dysferlin protein results in limb girdle muscular dystrophy type 2B and Miyoshi myopa
140 rlin, a member of the ferlin family, lead to limb girdle muscular dystrophy type 2B and Myoshi myopat
141  be therapeutically useful for patients with limb girdle muscular dystrophy type 2B.
142 oglycan (delta sgc), a mouse model for human limb girdle muscular dystrophy type 2F.
143 or several hereditary disorders that include limb girdle muscular dystrophy type 2H (LGMD2H), sarcotu
144 ed to two forms of muscular dystrophy called limb girdle muscular dystrophy type 2H and sarcotubular
145 nital muscular dystrophy type 1C (MDC1C) and limb girdle muscular dystrophy type 2I (LGMD2I).
146    Congenital muscular dystrophy type 1C and limb girdle muscular dystrophy type 2I are allelic, both
147 ad to both Walker-Warburg syndrome (WWS) and limb girdle muscular dystrophy type 2K (LGMD2K).
148 ions in any of the sarcoglycan genes lead to limb-girdle muscular dystrophies type 2C-2F.
149                                              Limb-girdle muscular dystrophy type 1A (LGMD1A) is an au
150 tations have been described in patients with limb-girdle muscular dystrophy type 1A (LGMD1A), myofibr
151 ery efforts for several disorders, including limb-girdle muscular dystrophy type 1A and the genes del
152                                              Limb-girdle muscular dystrophy type 1D (LGMD1D) is cause
153      One such example recently discovered is limb-girdle muscular dystrophy type 1D (LGMD1D), which i
154 d calpain-3 (CAPN3) the product of the human limb-girdle muscular dystrophy type 2A (LGMD2A) gene.
155 -lysosomal cysteine protease calpain 3 cause limb-girdle muscular dystrophy type 2A (LGMD2A).
156 the pathological signs in a murine model for limb-girdle muscular dystrophy type 2A after intramuscul
157 normal muscle physiology and in the study of limb-girdle muscular dystrophy type 2A in humans.
158                    Blots of muscle from nine limb-girdle muscular dystrophy type 2A patients with def
159  Genetic defects in calpain3 (CAPN3) lead to limb-girdle muscular dystrophy type 2A, a disease of the
160 the product of the gene that is defective in limb-girdle muscular dystrophy type 2A.
161 form underlie the human hereditary condition limb-girdle muscular dystrophy type 2A.
162  been identified as a novel gene involved in limb-girdle muscular dystrophy type 2B (LGMD2B) and its
163 identified which is mutated in patients with limb-girdle muscular dystrophy type 2B (LGMD2B) and with
164  gene, a gene which is also mutated in human limb-girdle muscular dystrophy type 2B (LGMD2B).
165                  Dysferlin deficiency causes limb-girdle muscular dystrophy type 2B (LGMD2B; proximal
166  to two clinically distinct muscle diseases, limb-girdle muscular dystrophy type 2B and Miyoshi myopa
167               Defects in dysferlin result in limb-girdle muscular dystrophy type 2B and Miyoshi myopa
168             The dysferlin gene is mutated in limb-girdle muscular dystrophy type 2B, Miyoshi myopathy
169                   One form of this disorder, limb-girdle muscular dystrophy type 2C (LGMD 2C), is pre
170 ssed gamma-sarcoglycan-null mice, a model of limb-girdle muscular dystrophy type 2C, with a Col6a2-de
171                                              Limb-girdle muscular dystrophy type 2D (LGMD 2D) is an a
172  Duchenne muscular dystrophy (DMD) patients, limb-girdle muscular dystrophy type 2D (LGMD2D) and thei
173                                              Limb-girdle muscular dystrophy type 2D (LGMD2D) is cause
174 ults in a severe form of muscular dystrophy (limb-girdle muscular dystrophy type 2D [LGMD2D]) without
175                                              Limb-girdle muscular dystrophy type 2E (LGMD 2E) is caus
176                          Autosomal recessive limb-girdle muscular dystrophy type 2G (LGMD2G) is an ad
177 ide ligase-ubiquitin ligase mutated in human limb-girdle muscular dystrophy type 2H (LGMD2H) and Bard
178                                              Limb-girdle muscular dystrophy type 2H (LGMD2H) and sarc
179 RIM32) cause two seemingly diverse diseases: limb-girdle muscular dystrophy type 2H (LGMD2H) or sarco
180 letal muscle and is orthologous to the human limb-girdle muscular dystrophy type 2H disease gene Trim
181 nally, mutations in the FKRP gene also cause limb-girdle muscular dystrophy type 2I (LGMD2I), a consi
182 sociated with FKRP mutations range from mild limb-girdle muscular dystrophy type 2I with predominantl
183 alleles in biopsies of 6 patients, 3 with an limb-girdle muscular dystrophy type 2J (LGMD2J) phenotyp
184 ked to several clinical phenotypes including limb-girdle muscular dystrophy type 2L and Miyoshi myopa
185                                              Limb-girdle muscular dystrophy, type 2A (LGMD 2A), is an
186 lasting alpha-sarcoglycan gene expression in limb-girdle muscular dystrophy, type 2D (LGMD2D) subject
187 phy, facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophies types 2A and 2B, Miyosh
188                                              Limb-girdle muscular dystrophy types 2E and F are charac
189  is observed in patients with other forms of limb-girdle muscular dystrophy where dystrophin and the
190                                              Limb girdle muscular dystrophy, which was described for
191 typic spectrum of GMPPB mutations to include limb-girdle muscular dystrophies with adult onset with o
192 mutations are responsible for congenital and limb-girdle muscular dystrophies with hypoglycosylation
193                  Here we review each form of limb-girdle muscular dystrophy with attention to molecul
194 e most severe form of dystroglycanopathy, to limb-girdle muscular dystrophy with cognitive defects.
195 e limited to patients with Duchenne-like and limb-girdle muscular dystrophy with normal dystrophin an
196 and structural eye defects to a mild form of limb-girdle muscular dystrophy with onset in adult life
197 the prevalence among patients with proximal (limb-girdle) muscular dystrophy with a later onset was 6
198 lities and intellectual delay to adult-onset limb-girdle muscular dystrophies without mental retardat

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top